Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq
Insider Sale
+$410,889
-1.42%
Shares
Shares Volume: 14,936 Shares
Average Share Price: $27.51
INSIDER
Kintz Samuel
PRESIDENT AND CEO (Director)
reported on Oct 8 2024
traded on Oct 4 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 1,033,793 |
| PURCHASES/SALES 1Y | 0 / 15 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $259,590.25 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
| PURCHASES/SALES 1Y | 0 / 88 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $908,954.44 |
| COMPANY PREVIOUS TRADES |